• Dry Cracked Skin
  • Impetigo
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Surgery
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Inflamed Skin

Vaulting Forth the Vaccine


Boston - Cancer researchers have developed an experimental vaccine that showed promising results in early stage testing for the treatment of metastatic melanoma. The vaccine, which is made by transferring a gene into a patient's own melanoma cells, caused an immune system attack against melanoma tumors, with nearly one-third of 35 patients alive after three years, and four of them with no signs of the disease.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.